Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1107 of 1,261
  1. US 7078412

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall Prodesfarma S.A. · Granted Jul 18, 2006 · Expires Jul 13, 2026

    granted
  2. US 2006153775

    Compounds for targeting endothelial cells, compositions containing the same and methods for their use

    BRACCO INT BV [NL] · Granted Jul 13, 2006 · Expires Jul 8, 2026

    granted
  3. US 7074410

    Modified HCV peptide vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  4. US 7074765

    Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  5. US 7074893

    Methods and compositions for the treatment of diseases associated with signal transduction aberrations

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  6. US 7074938

    Method for the synthesis of soritin compounds

    The Regents of the University of California · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  7. US 7074900

    Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin

    The Regents of the University of California · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  8. US 7074890

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  9. US 7074924

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  10. US 7074782

    Carbamate caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  11. US 7074761

    Peptides and production and use thereof

    Takeda Chemical Ind., Ltd. · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  12. US 7074760

    Polyacid glycopeptide derivatives

    Theravance, Inc. · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  13. US 7074554

    Antibodies specific for NEBR1 and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  14. US 7073512

    Adhesion prevention and an endoscopic insufflation system therefor

    Saturnus AG · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  15. AU 2001289696

    New use of lipase inhibitors

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] · Granted Jul 6, 2006 · Expires Jul 1, 2026

    granted
  16. US 7070771

    Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells

    The Regents of the University of California · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  17. US 7071293

    Alpha helical peptides with broad spectrum antimicrobial activity that are insensitive to salt

    The Regents of the University of California · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  18. US 7070790

    Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  19. US 7070957

    STARS—a muscle-specific actin-binding protein

    The Board of Regents of the University of Texas System · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  20. US 7070805

    Rapidly disintegrable solid preparation

    Takeda Pharmaceutical Company Limited · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  21. US 7070956

    Peptides and derivatives thereof showing cell attachment, spreading and detachment activity

    REGENBiotech, Inc. · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  22. US 7070788

    Follicle stimulating hormone superagonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  23. US 7070607

    Bioabsorbable polymeric implants and a method of using the same to create occlusions

    The Regents of the University of California · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  24. US 7070971

    Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6

    The Regents of the University of California · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.